DPIIT recognised startup Government of India
Startup India
Maxbloom Pharmaceutical Private Limited
Maxbloom Pharmaceutical Private Limited - pharma in Solapur, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2024
₹1.86 Lakh
▼ 38% YoY
Net loss · FY 2024
₹4.33 Lakh
Net margin -232.9%
EBITDA · FY 2024
-₹3.65 Lakh
EBITDA margin -196.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Maxbloom Pharmaceutical Private Limited
Data last updated:
Maxbloom Pharmaceutical Private Limited is a private limited company based in Solapur, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24290PN2021PTC205706.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Fattesing Mahadevsing Chavan and Sagarsingh Marutisingh Chouhan.
Its last annual general meeting (AGM) was held on 18 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pl No 3A Mahaveer Society, Solapur, Maharashtra, India – 413004.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.86 Lakh, a decline of 38% compared to the previous year. For the same year it recorded a net loss of ₹4.33 Lakh (net margin -232.9%) and EBITDA of -₹3.65 Lakh (EBITDA margin -196.5%).
Company Details of Maxbloom Pharmaceutical Private Limited
CIN U24290PN2021PTC205706
Registration Number 205706
Incorporation Date 29 October 2021
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 18 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Maxbloom Pharmaceutical
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPl No 3A Mahaveer Society, Solapur, Maharashtra, India – 413004
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Maxbloom Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Maxbloom Pharmaceutical Private Limited
The main business activity of Maxbloom Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Maxbloom Pharmaceutical Private Limited FY 2025 filings available
Maxbloom Pharmaceutical Private Limited reported revenue of ₹1.86 Lakh (down 38% YoY) for FY 2024.
Revenue · FY 2024
₹1.86 Lakh ▼ 38%
Net loss · FY 2024
₹4.33 Lakh margin -232.9%
EBITDA · FY 2024
-₹3.65 Lakh margin -196.5%
Compounded Annual Growth Rate (CAGR) of Maxbloom Pharmaceutical Private Limited
Revenue CAGR growth
1 year
▼ 38%
EBITDA CAGR growth
1 year
▼ 15%
Revenue fell 38% in the latest year. EBITDA fell 15% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Maxbloom Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹3.65 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.33 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Maxbloom Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -196.5% | •••• | •••• |
| Net Profit Margin | -232.9% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maxbloom Pharmaceutical are in the company report.
Premium access
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Maxbloom Pharmaceutical Private Limited
Maxbloom Pharmaceutical has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Fattesing Mahadevsing Chavan | Director | 29 Oct 2021 | 4 Years 11 Months | Current |
| Sagarsingh Marutisingh Chouhan | Director | 29 Oct 2021 | 4 Years 11 Months | Current |
Peer Comparison of Maxbloom Pharmaceutical Private Limited
Maxbloom Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Real & Natural Herbals Private Limited | ₹1.88 Lakh (FY 2021) | •••• | •••• | •••• | Roorkee, Uttarakhand, India | |
| Niyanshi Minerals Private Limited | ₹1.88 Lakh (FY 2023) | •••• | •••• | -95.0% | •••• | Pali, Rajasthan, India |
| Healing Heritage Producer Company Limited | ₹1.87 Lakh (FY 2018) | •••• | •••• | -30.0% | •••• | Cuttack, Odisha, India |
| Henwel Bioherb Spagyric Industries Private Limited | ₹1.87 Lakh (FY 2024) | •••• | •••• | -53.0% | •••• | Kushinagar, Uttar Pradesh, India |
| Nuvitol Pharmaceuticals Private Limited | ₹1.87 Lakh (FY 2023) | •••• | •••• | 56.0% | •••• | Bangalore, Karnataka, India |
| Maxbloom Pharmaceutical Private Limited this company | ₹1.86 Lakh (FY 2024) | •••• | •••• | -38.0% | •••• | Solapur, Maharashtra, India |
| Swastika Ayurveda Private Limited | ₹1.85 Lakh (FY 2023) | •••• | •••• | -76.0% | •••• | Thiruvananthapuram, Kerala, India |
| Cerca Trova Cosmetics Private Limited | ₹1.85 Lakh (FY 2020) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Hygge Wellness Private Limited | ₹1.85 Lakh (FY 2025) | •••• | •••• | 667.0% | •••• | Navi Mumbai, Maharashtra, India |
| Aranio Healthcare Private Limited | ₹1.85 Lakh (FY 2024) | •••• | •••• | 30.0% | •••• | Patna, Bihar, India |
| Ayudhi Life Science Private Limited | ₹1.85 Lakh (FY 2022) | •••• | •••• | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Maxbloom Pharmaceutical by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Maxbloom Pharmaceutical Private Limited
Maxbloom Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Maxbloom Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Maxbloom Pharmaceutical.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Maxbloom Pharmaceutical Private Limited
Maxbloom Pharmaceutical Private Limited has 6 board changes on record since 2021: 2 appointments and 4 cessations. The latest: Bhagat Singh Dasharathsingh Singh ceased to be Additional Director on 24 Oct 2022.
AGM
Maxbloom Pharmaceutical Private Limited last Annual general meeting of members was held on 18 Sep 2025 as per latest MCA records.
Filing
Maxbloom Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Ceased
Bhagat Singh Dasharathsingh Singh ceased to be Additional Director.
Ceased
Jayashri Fattesingh Chouhan ceased to be Additional Director.
Ceased
Neha Sangramsingh Chouhan ceased to be Additional Director.
Ceased
Vijayalaxmi Marutising Chavan ceased to be Additional Director.
Appointed
Fattesing Mahadevsing Chavan was appointed as Director.
Appointed
Sagarsingh Marutisingh Chouhan was appointed as Director.
Incorporation
29 Oct 2021
Maxbloom Pharmaceutical Private Limited was registered on 29 Oct 2021 with Roc Pune & aged 4 years 11 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Maxbloom Pharmaceutical Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maxbloom Pharmaceutical Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maxbloom Pharmaceutical Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maxbloom Pharmaceutical Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maxbloom Pharmaceutical Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maxbloom Pharmaceutical Private Limited
Maxbloom Pharmaceutical is an active private limited company based in Solapur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 October 2021 (5+ years old) and is registered under CIN U24290PN2021PTC205706.
Maxbloom Pharmaceutical reported revenue of ₹1.86 Lakh for FY 2024 (down 38% YoY).
Maxbloom Pharmaceutical has 2 current directors:
- Fattesing Mahadevsing Chavan - Director
- Sagarsingh Marutisingh Chouhan - Director
Maxbloom Pharmaceutical reported a net loss of ₹4.33 Lakh (net margin -232.9%) and EBITDA of -₹3.65 Lakh (EBITDA margin -196.5%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Maxbloom Pharmaceutical is U24290PN2021PTC205706. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxbloom Pharmaceutical was incorporated on 29 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Maxbloom Pharmaceutical by revenue are Real & Natural Herbals Private Limited, Niyanshi Minerals Private Limited, Healing Heritage Producer Company Limited, Henwel Bioherb Spagyric Industries Private Limited, Nuvitol Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhagat Singh Dasharathsingh Singh ceased to be Additional Director on 24 Oct 2022. Jayashri Fattesingh Chouhan ceased to be Additional Director on 24 Oct 2022. Neha Sangramsingh Chouhan ceased to be Additional Director on 24 Oct 2022. Maxbloom Pharmaceutical has 6 board changes on record in total.
Yes, Maxbloom Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Maxbloom Pharmaceutical is at Pl No 3A Mahaveer Society, Solapur, Maharashtra, India – 413004.
Maxbloom Pharmaceutical has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.